Interstitial Lung Disease > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Kreuter, Michael; Herth, Felix J. F.; Wacker, Margarethe; Leidl, Reiner; Hellmann, Andreas; Pfeifer, Michael; Behr, Jürgen; Witt, Sabine; Kauschka, Dagmar (2015). "Exploring Clinical and Epidemiological Traits of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry-The Thrilling-ILD Registry". GBD 2015 Mortality and Causes of Death Collaborators (8 October 2016). "Global, regional, and nationwide life expectancy, all-trigger mortality, and cause-particular mortality for 249 causes of dying, 1980-2015: a scientific analysis for the worldwide Burden of Disease Study 2015".

Lancet. Cottin, Vincent (November 2016). "Lung biopsy in interstitial lung illness: balancing the chance of surgery and diagnostic uncertainty". Ryu JH, Olson EJ, Midthun DE, Swensen SJ (November 2002). "Diagnostic method to the affected person with diffuse lung disease". For some forms of paediatric ILDs and few types adult ILDs, vapeverkaufen genetic causes have been recognized. Idiopathic interstitial pneumonia is the time period given to ILDs with an unknown trigger.

ILD could also be classified as to whether its trigger will not be recognized (idiopathic) or recognized (secondary). However, prognosis varies extensively relying on the specific sort and trigger of ILD; some inflammatory varieties might stabilize or enhance with treatment.

As disease development will increase and the lungs grow to be stiffer lung volumes will proceed to lower; lower TLC, RV, FVC and FEV1 scores are associated with a more extreme illness development and poorer prognosis.

Pulmonary operate testing is indicated for all folks with ILD and the FVC loss and DLCO is prognostic, vapebestuk with an FVC loss of greater than 5% per 12 months associated with a poor prognosis in fibrosis subtypes of ILD. Life expectancy after lung transplant is 5.2 years in these with idiopathic interstitial pneumonias (together with idiopathic pulmonary fibrosis) and 6.7 years in those with other varieties of ILD. Pirfenidone was associated with a 45% less decline in FVC at 52 weeks compared to placebo in a trial involving folks with idiopathic pulmonary fibrosis, and was associated with a slower FVC decline in those with progressive pulmonary fibrosis.

Deterding, Robin; Young, Lisa R.; DeBoer, Emily M.; Warburton, David; Cunningham, Steven; Schwerk, Nicolaus; Flaherty, Kevin R.; Brown, Kevin K.; Dumistracel, Mihaela; Erhardt, Elvira; Bertulis, Julia; Gahlemann, Martina; Stowasser, Susanne; Griese, Matthias; InPedILD trial investigators (February 2023). "Nintedanib in kids and adolescents with fibrosing interstitial lung diseases". Hayes D, Jr; Wilson, KC; Krivchenia, vapeprix [you can check here] K; Hawkins, SMM; Balfour-Lynn, IM; Gozal, D; Panitch, HB; Splaingard, ML; Rhein, LM; Kurland, vapeprix G; Abman, Vapeeliquids SH; Hoffman, TM; Carroll, CL; Cataletto, ME; Tumin, D; Oren, E; Martin, RJ; Baker, J; Porta, GR; Kaley, D; Gettys, A; Deterding, RR (1 February 2019).

"Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline".

Troy, Lauren K; Grainge, vapecigarette (https://www.vapecigarette.fr/) Christopher; Corte, vapearomen Tamera J (February 2020).